Multi-institutional phase 2 study of TLK286 (TELCYTA, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer (Q46598239)
Jump to navigation
Jump to search
scientific article published in July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multi-institutional phase 2 study of TLK286 (TELCYTA, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer |
scientific article published in July 2005 |
Statements
1 reference
Multi-institutional phase 2 study of TLK286 (TELCYTA, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer (English)
1 reference
Kavanagh JJ
1 reference
Gershenson DM
1 reference
Choi H
1 reference
Lewis L
1 reference
Patel K
1 reference
Brown GL
1 reference
Garcia A
1 reference
Spriggs DR
1 reference
1 July 2005
1 reference
15
1 reference
4
1 reference
593-600
1 reference